Active	Status	Sponsor type	Region	Phase	Filter
2 Active 0 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Vecchiet, Jacopo
AMMURAVID, NCT04832880 / 2020-001854-23: Factorial Randomized Trial of Rendesivir and Baricitinib Plus Dexamethasone for COVID-19 (the Trial)	Not yet recruiting	3	4000	Europe	Baricitinib Oral Tablet [Olumiant], Olumiant, Remdesivir, Veklury, Dexamethasone	ASST Fatebenefratelli Sacco, AIFA	Covid19	03/22	12/22
MANTICO 2, NCT05321394: Non-inferiority Trial on Treatments in Early COVID-19	Completed	3	536	Europe	Sotrovimab, Tixagevimab Cilgavimab, Nirmatrelvir Ritonavir	Azienda Ospedaliera Universitaria Integrata Verona, Agenzia Italiana del Farmaco, Azienda Sanitaria-Universitaria Integrata di Udine	COVID-19	10/23	10/23